Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Dominique Fontanilla,1
Molly Johannessen,2
Abdol R. Hajipour,3
Nicholas V. Cozzi,1
Meyer B. Jackson,2
Arnold E. Ruoho1*
Abstract:
The sigma-1 receptor is widely distributed in the central nervoussystem and periphery. Originally mischaracterized as an opioidreceptor, the sigma-1 receptor binds a vast number of syntheticcompounds but does not bind opioid peptides; it is currentlyconsidered an orphan receptor. The sigma-1 receptor pharmacophoreincludes an alkylamine core, also found in the endogenous compoundN,N-dimethyltryptamine (DMT). DMT acts as a hallucinogen, butits receptor target has been unclear. DMT bound to sigma-1 receptorsand inhibited voltage-gated sodium ion (Na+) channels in bothnative cardiac myocytes and heterologous cells that expresssigma-1 receptors. DMT induced hypermobility in wild-type micebut not in sigma-1 receptor knockout mice. These biochemical,physiological, and behavioral experiments indicate that DMTis an endogenous agonist for the sigma-1 receptor.
1 Department of Pharmacology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA. 2 Department of Physiology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA. 3 Pharmaceutical Research Laboratory, Department of Chemistry, Isfahan University of Technology, Isfahan 84156, IR Iran.
* To whom correspondence should be addressed. E-mail: aeruoho{at}wisc.edu
The editors suggest the following Related Resources on Science sites:
In Science Signaling
PERSPECTIVES
Tsung-Ping Su, Teruo Hayashi, and D. Bruce Vaupel (10 March 2009) Sci. Signal.2 (61), pe12.
[DOI: 10.1126/scisignal.261pe12] |Abstract »|Full Text »|PDF »
EDITORS' CHOICE
Peter Stern (17 February 2009) Sci. Signal.2 (58), ec57.
[DOI: 10.1126/scisignal.258ec57] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Lifetime of UDP-galactose:Ceramide Galactosyltransferase Is Controlled by a Distinct Endoplasmic Reticulum-associated Degradation (ERAD) Regulated by Sigma-1 Receptor Chaperones.
T. Hayashi, E. Hayashi, M. Fujimoto, H. Sprong, and T.-P. Su (2012)
J. Biol. Chem.
287, 43156-43169
|Abstract »|Full Text »|PDF »
{sigma}-1 Receptor at the Mitochondrial-Associated Endoplasmic Reticulum Membrane Is Responsible for Mitochondrial Metabolic Regulation.
K.-S. C. Marriott, M. Prasad, V. Thapliyal, and H. S. Bose (2012)
J. Pharmacol. Exp. Ther.
343, 578-586
|Abstract »|Full Text »|PDF »
The Sigma-1 Receptor Binds to the Nav1.5 Voltage-gated Na+ Channel with 4-Fold Symmetry.
D. Balasuriya, A. P. Stewart, D. Crottes, F. Borgese, O. Soriani, and J. M. Edwardson (2012)
J. Biol. Chem.
287, 37021-37029
|Abstract »|Full Text »|PDF »
The sigma-1 receptor: a molecular chaperone for the heart and the soul?.
Y. Ha, A. Saul, A. Tawfik, C. Williams, K. Bollinger, R. Smith, M. Tachikawa, E. Zorrilla, V. Ganapathy, and S. B. Smith (2011)
Invest. Ophthalmol. Vis. Sci.
52, 7749-7760
|Abstract »|Full Text »|PDF »
Sig1R Protein Regulates hERG Channel Expression through a Post-translational Mechanism in Leukemic Cells.
D. Crottes, S. Martial, R. Rapetti-Mauss, D. F. Pisani, C. Loriol, B. Pellissier, P. Martin, E. Chevet, F. Borgese, and O. Soriani (2011)
J. Biol. Chem.
286, 27947-27958
|Abstract »|Full Text »|PDF »
In Vivo Long-Term Kinetics of Radiolabeled N,N-Dimethyltryptamine and Tryptamine.
A. A. Vitale, A. B. Pomilio, C. O. Canellas, M. G. Vitale, E. M. Putz, and J. Ciprian-Ollivier (2011)
J. Nucl. Med.
52, 970-977
|Abstract »|Full Text »|PDF »
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
F. G. Revel, J.-L. Moreau, R. R. Gainetdinov, A. Bradaia, T. D. Sotnikova, R. Mory, S. Durkin, K. G. Zbinden, R. Norcross, C. A. Meyer, et al. (2011)
PNAS
108, 8485-8490
|Abstract »|Full Text »|PDF »
Antagonist action of progesterone at {sigma}-receptors in the modulation of voltage-gated sodium channels.
M. Johannessen, D. Fontanilla, T. Mavlyutov, A. E. Ruoho, and M. B. Jackson (2011)
Am J Physiol Cell Physiol
300, C328-C337
|Abstract »|Full Text »|PDF »
Detergent-Resistant Microdomains Determine the Localization of {sigma}-1 Receptors to the Endoplasmic Reticulum-Mitochondria Junction.
Regulation of {sigma}-1 Receptors and Endoplasmic Reticulum Chaperones in the Brain of Methamphetamine Self-Administering Rats.
T. Hayashi, Z. Justinova, E. Hayashi, G. Cormaci, T. Mori, S.-Y. Tsai, C. Barnes, S. R. Goldberg, and T.-P. Su (2010)
J. Pharmacol. Exp. Ther.
332, 1054-1063
|Abstract »|Full Text »|PDF »
Sigma-1 Receptors Regulate Bcl-2 Expression by Reactive Oxygen Species-Dependent Transcriptional Regulation of Nuclear Factor {kappa}B.
Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1{middle dot}GTP pathway.
S.-Y. Tsai, T. Hayashi, B. K. Harvey, Y. Wang, W. W. Wu, R.-F. Shen, Y. Zhang, K. G. Becker, B. J. Hoffer, and T.-P. Su (2009)
PNAS
106, 22468-22473
|Abstract »|Full Text »|PDF »
Voltage-gated sodium channel modulation by {sigma}-receptors in cardiac myocytes and heterologous systems.
M. Johannessen, S. Ramachandran, L. Riemer, A. Ramos-Serrano, A. E. Ruoho, and M. B. Jackson (2009)
Am J Physiol Cell Physiol
296, C1049-C1057
|Abstract »|Full Text »|PDF »
When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor.